Novel Drug Delivery Systems for the Treatment of Skin Disorders
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 November 2025 | Viewed by 1921
Special Issue Editors
2. Formulation and Technology of Drugs Research Center, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
Interests: drug formulation; topical drug delivery systems and cosmetics (ointments, lipophilic and hydrophilic creams, hydrogels, oleogels, bigels, nanoparticulate and microparticulate systems); physicochemical, rheological and textural evaluation of topical drug delivery systems and cosmetics
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; drug formulation; topical drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of dermatology has achieved significant advancements with the advent of novel drug delivery systems that offer more effective treatments for skin disorders. These systems harness nanotechnology, such as nanoparticles, microemulsions, nanoemulsions, solid lipid nanoparticles (SLNs), microsponges, nanosponges, vesicular systems (liposomes, ethosomes, and niosomes), and 3D printing technologies, which enhances the penetration and permeation of therapeutic agents through the skin's protective barrier, enabling more targeted and potent treatments.
In summary, these innovative drug delivery systems hold promise for more effective and safe therapies, optimizing the management of skin disorders in dermatology.
In this Special Issue, original research articles and reviews are welcome to be submitted.
We look forward to receiving your contributions.
Dr. Ioana Viorica Olariu
Dr. Vicenţiu Vlaia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanoparticles
- vesicular systems
- 3D-printed drugs
- topical dosage form
- skin disorder
- penetration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
